Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Coryell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|April 21, 2022
Targeting cellular senescence as a novel treatment for osteoarthritisEmma M Astrike-Davis, Philip Coryell, Richard F Loeser
Biorxiv : the Preprint Server for Biology|November 28, 2024
Response splicing QTLs in primary human chondrocytes identifies putative osteoarthritis risk genesSeyoun Byun, Philip Coryell, Nicole Kramer, et al.
Nature Communications|August 26, 2025
Response splicing quantitative trait loci in primary human chondrocytes identify putative osteoarthritis risk genesSeyoun Byun, Jacqueline Shine, Philip Coryell, et al.
Elife|June 6, 2019
Correction: Rapid DNA replication origin licensing protects stem cell pluripotencyJacob Peter Matson, Raluca Dumitru, Philip Coryell, et al.
Elife|November 18, 2017
Rapid DNA replication origin licensing protects stem cell pluripotencyJacob Peter Matson, Raluca Dumitru, Philip Coryell, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2024
Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis riskNicole E Kramer, Seyoun Byun, Philip Coryell, et al.
Cell Genomics|January 9, 2025
Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis riskNicole E Kramer, Seyoun Byun, Philip Coryell, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|April 21, 2022
Targeting cellular senescence as a novel treatment for osteoarthritisEmma M Astrike-Davis, Philip Coryell, Richard F Loeser
Biorxiv : the Preprint Server for Biology|November 28, 2024
Response splicing QTLs in primary human chondrocytes identifies putative osteoarthritis risk genesSeyoun Byun, Philip Coryell, Nicole Kramer, et al.
Nature Communications|August 26, 2025
Response splicing quantitative trait loci in primary human chondrocytes identify putative osteoarthritis risk genesSeyoun Byun, Jacqueline Shine, Philip Coryell, et al.
Elife|June 6, 2019
Correction: Rapid DNA replication origin licensing protects stem cell pluripotencyJacob Peter Matson, Raluca Dumitru, Philip Coryell, et al.
Elife|November 18, 2017
Rapid DNA replication origin licensing protects stem cell pluripotencyJacob Peter Matson, Raluca Dumitru, Philip Coryell, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2024
Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis riskNicole E Kramer, Seyoun Byun, Philip Coryell, et al.
Cell Genomics|January 9, 2025
Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis riskNicole E Kramer, Seyoun Byun, Philip Coryell, et al.
Pageof 1